WESPAC Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
9,495
+7,248
| +323% | +$804K | 0.74% | 42 |
|
|
2025
Q1 | $252K | Buy |
+2,247
| New | +$252K | 0.21% | 136 |
|
|
2024
Q2 | – | Sell |
-2,885
| Closed | -$211K | – | 161 |
|
|
2024
Q1 | $211K | Sell |
2,885
-44
| -2% | -$3.22K | 0.12% | 157 |
|
|
2023
Q4 | $237K | Buy |
2,929
+1
| +0% | +$81 | 0.16% | 133 |
|
|
2023
Q3 | $219K | Buy |
+2,928
| New | +$219K | 0.16% | 130 |
|
|
2016
Q2 | – | Sell |
-15,112
| Closed | -$1.39M | – | 111 |
|
|
2016
Q1 | $1.39M | Buy |
+15,112
| New | +$1.39M | 1.73% | 15 |
|
|
2014
Q2 | – | Sell |
-14,190
| Closed | -$1.01M | – | 119 |
|
|
2014
Q1 | $1.01M | Buy |
14,190
+1,692
| +14% | +$120K | 0.87% | 37 |
|
|
2013
Q4 | $939K | Buy |
12,498
+6,191
| +98% | +$465K | 0.78% | 50 |
|
|
2013
Q3 | $397K | Buy |
+6,307
| New | +$397K | 0.46% | 80 |
|